PB2129: THE MODAKAFUSP ALFA IINNOVATE CLINICAL DEVELOPMENT PROGRAM: RATIONALE AND DESIGN OF 3 PHASE 1/2 TRIALS OF AN INNATE IMMUNITY ENHANCER FOR MULTIPLE MYELOMA (MM) Journal Articles uri icon

  •  
  • Overview
  •  
  • Research
  •  
  • Identity
  •  
  • Additional Document Info
  •  
  • View All
  •  

authors

  • Holstein, Sarah A
  • Mian, Hira
  • Touzeau, Cyrille
  • Kingsley, Edwin
  • Vogl, Dan
  • Zuniga, Richard
  • Suryanarayan, Kaveri
  • Wang, Shining
  • Thesillat-Versmee, Laura
  • Liu, Yuyin
  • Chen, Tian
  • Zhang, Yefei
  • Parot, Xavier
  • Lee, Hans C